The effect of MCT Oil on COVID-19

Not Applicable

• Conditions: Coronavirus COVID-19.; U07.1; COVID-19

• Registration Number: IRCT20160313027033N2
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients with mild or moderate COVID-19 disease according to the diagnostic protocol provided by the Ministry of Health

Exclusion Criteria

No allergic to MCT (for those who have previously taken MCT and know they are allergic).

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Temperature. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Thermometer.;Cough (severity-frequency). Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Fisman Cough Severity Score.;Weakness. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Respiratory rate. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Counting the number of breaths per minute.;Muscular pain. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Urine Ketone. Timepoint: Four hours after taking MCT oil. Method of measurement: It is checked with a urine test strip.

Secondary Outcome Measures

Name	Time	Method
Hospital admssion. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Ratio of the number of admission to total patients in each group.;Mortality. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Ratio of the number of deaths to total patients in each group.